Where does your plant stand on AI readiness?
BAMI is the AI overlay on BioPhorum's DPMM and DISCO — a six-level index scoring biologics manufacturing across five dimensions. Quick takes about five minutes; Detailed goes deep.
Results
Quick Radar
Detailed Heat Map
Why it matters
01
Regulators are converging
EMA, EFPIA, FDA and the draft EU GMP Annex 22 now define what “acceptable” AI looks like in GxP. Maturity is a CYA concern, not just aspiration.
02
AI is gated by digital readiness
Most plants sit at mid-maturity. Without data integration and sponsor–CDMO interfaces, AI stalls at local pilots.
03
The gap is operational
Skills, model ownership, and incentives — not algorithms — decide whether AI becomes durable advantage.
What you'll get
A maturity level, 0–5
Where your plant sits on the BAMI scale, from siloed/manual to AI-native.
Scores across 5 dimensions
Data, models, governance, portability, and inspection readiness — see your bottlenecks.
Recommended next steps
Your biggest bottleneck and the specific actions to move up a level.
AI in Biomanufacturing — 2026–2029 Outlook
The Axio white paper that introduces BAMI. The framework, the ecosystem, the playbook.